Stamaril

Stamaril Special Precautions

vaccine, yellow fever

Manufacturer:

Sanofi Pasteur
Full Prescribing Info
Special Precautions
STAMARIL PASTEUR should not be administered by the intravascular route: ensure that the needle does not enter any blood vessel.
In the case of HIV-positive patients who are symptomatic, in whom CD4 levels are below 200/mm3 or those with a high viral load, it is preferable to avoid vaccination against yellow fever.
Vaccination may be undertaken in other HIV-positive patients.
In certain particular cases, vaccination against yellow fever may be planned in patients who have received immunosuppressant therapy; it is wise to delay vaccination for a month after treatment discontinuation, when the return to normal in all cases of all laboratory parameters has been verified.
A tolerability test is indicated in allergic subjects: if intradermal injection of 0.1 ml vaccine is not followed within 10 to 15 minutes by any reaction, the remaining 0.4 ml may be injected via the subcutaneous route.
It is preferable to delay vaccination in the event of fever, acute disease or active chronic disease.
Inform the doctor in the event of: Illness with or without fever; Any ongoing treatment affecting organism defenses; 65 years old & above (increase of the frequency of serious undesirable effects lasting more than 48 hours); HIV-seropositive; Suffer from allergy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in